Synonym
CMG002; CMG 002; CMG-002;
IUPAC/Chemical Name
isopropyl 4-((6-(6-chloro-5-((2,4-difluorophenyl)sulfonamido)pyridin-3-yl)pyrido[3,2-d]pyrimidin-4-yl)amino)piperidine-1-carboxylate
InChi Key
NERMYQPTYCTEDU-UHFFFAOYSA-N
InChi Code
InChI=1S/C27H26ClF2N7O4S/c1-15(2)41-27(38)37-9-7-18(8-10-37)34-26-24-21(32-14-33-26)5-4-20(35-24)16-11-22(25(28)31-13-16)36-42(39,40)23-6-3-17(29)12-19(23)30/h3-6,11-15,18,36H,7-10H2,1-2H3,(H,32,33,34)
SMILES Code
FC1=CC=C(S(NC2=C(Cl)N=CC(C3=NC4=C(NC5CCN(C(OC(C)C)=O)CC5)N=CN=C4C=C3)=C2)(=O)=O)C(F)=C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
618.06
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Kim MN, Lee SM, Kim JS, Hwang SG. Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. Cancer Chemother Pharmacol. 2019 Oct;84(4):809-817. doi: 10.1007/s00280-019-03918-y. Epub 2019 Aug 5. PMID: 31385002.
2: Kim MY, Kruger AJ, Jeong JY, Kim J, Shin PK, Kim SY, Cho JY, Hahm KB, Hong SP. Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein-Barr Virus-Infected Gastric Cancer Cells. Mol Cells. 2019 Jun 30;42(6):448-459. doi: 10.14348/molcells.2019.2395. PMID: 31085812; PMCID: PMC6602147.
3: Choi HJ, Heo JH, Park JY, Jeong JY, Cho HJ, Park KS, Kim SH, Moon YW, Kim JS, An HJ. A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer. Gynecol Oncol. 2019 Apr;153(1):135-148. doi: 10.1016/j.ygyno.2019.01.012. Epub 2019 Jan 25. PMID: 30686552.